GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Angptl4 | affects response to substance | EXP | | 6480464 | CTD | ANGPTL4 affects the susceptibility to Dexamethasone | PMID:19628874 | Angptl4 | decreases expression | EXP | | 6480464 | CTD | Dexamethasone results in decreased expression of ANGPTL4 mRNA | PMID:22733784 | Angptl4 | increases expression | EXP | | 6480464 | CTD | Dexamethasone results in increased expression of ANGPTL4 mRNA | PMID:19628874 | Angptl4 | increases response to substance | EXP | | 6480464 | CTD | ANGPTL4 gene mutant form results in increased susceptibility to Dexamethasone | PMID:31053639 | Angptl4 | multiple interactions | EXP | | 6480464 | CTD | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ANGPTL4 mRNA; [ANGPTL4 gene mutant form results in increased susceptibility to Dexamethasone] which results in decreased expression of FASN mRNA; [ANGPTL4 gene mutant form results in increased susceptibility to Dexamethasone] which results in decreased expression of MLXIPL mRNA; [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mRNA; [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mRNA]; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of ACACA mRNA]; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of ACACB mRNA]; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of AGPAT3 mRNA]; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of CD36 mRNA]; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of LPIN1 mRNA]; ANGPTL4 gene mutant form inhibits the reaction [Dexamethasone results in decreased expression of MLXIPL mRNA alternative form]; ANGPTL4 gene mutant form promotes the reaction [Dexamethasone results in decreased expression of SREBF1 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ANGPTL4 mRNA] | PMID:16054899 PMID:23428407 PMID:31053639 | Angptl4 | increases expression | ISO | Angptl4 (Rattus norvegicus) | 6480464 | CTD | Dexamethasone results in increased expression of ANGPTL4 mRNA | PMID:20032058 | Angptl4 | multiple interactions | ISO | Angptl4 (Rattus norvegicus) | 6480464 | CTD | Dexamethasone inhibits the reaction [Freund's Adjuvant results in decreased expression of ANGPTL4 mRNA]; Testosterone inhibits the reaction [Dexamethasone results in increased expression of ANGPTL4 mRNA] | PMID:20032058 PMID:21149847 | |
Go Back to source page | Continue to Ontology report |